EW News and Press, Edwards Lifesciences Corporation From 02/21/22

The decline from September 2021 in Medical Device stocks was healthy. Similar price structures provide confidence in coming upside. Boston Scientific is a chart that we are much more enthused about. For further details see: Riding The Stock Waves: Update On The Medical D...

Updating its Tactical U.S. Equity Themes, UBS introduced a new theme of Selloff Opporutunities. The screen "highlights a list of companies that look attractive following recent market volatility." "We believe some stocks have been unfairly punished in the sell-off," UBS' theme team wrote in a...

Fisher’s 13F portfolio value increased from ~$161B to ~$179B in Q4 2021. Amazon, Netflix, Meta Platforms, and PayPal Holdings were increased while reducing Visa, Cisco Systems, Walt Disney, Intel, Wal-Mart, UnitedHealth, and Starbucks this quarter. The top three positions a...

Following a decline of more than 15% in January, Edwards Lifesciences (NYSE:EW) has bounced back after UBS upgraded the cardiac equipment company to Buy from Neutral, citing its potential in the market of Transcatheter Aortic Valve Replacement (TAVR). Justifying the decision, the analysts led...

Image source: The Motley Fool. Edwards Lifesciences (NYSE: EW) Q4 2021 Earnings Call Jan 26, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Edwards Lifesciences (EW) Q4 2021 Earnings Call Transcript

EDWARDS LIFESCIENCES REPORTS FOURTH QUARTER RESULTS PR Newswire IRVINE, Calif. , Jan. 26, 2022 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended December 31, 2021. Fourth Quarter Highli...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JANUARY 26, 2022 PR Newswire IRVINE, Calif. , Jan. 19, 2022 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2021 after the mark...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

EDWARDS LIFESCIENCES TO PRESENT AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE PR Newswire IRVINE, Calif. , Jan. 5, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate at the J.P. Morgan Healthcare Confe...